BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 32262883)

  • 1. In vitro biocompatibility of mesoporous metal (III; Fe, Al, Cr) trimesate MOF nanocarriers.
    Grall R; Hidalgo T; Delic J; Garcia-Marquez A; Chevillard S; Horcajada P
    J Mater Chem B; 2015 Nov; 3(42):8279-8292. PubMed ID: 32262883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biocompatible porous metal-organic framework nanoparticles based on Fe or Zr for gentamicin vectorization.
    Unamuno X; Imbuluzqueta E; Salles F; Horcajada P; Blanco-Prieto MJ
    Eur J Pharm Biopharm; 2018 Nov; 132():11-18. PubMed ID: 30179739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adsorptive Separation of Acetylene from Light Hydrocarbons by Mesoporous Iron Trimesate MIL-100(Fe).
    Yoon JW; Lee JS; Lee S; Cho KH; Hwang YK; Daturi M; Jun CH; Krishna R; Chang JS
    Chemistry; 2015 Dec; 21(50):18431-8. PubMed ID: 26515022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Understanding the colloidal stability of the mesoporous MIL-100(Fe) nanoparticles in physiological media.
    Bellido E; Guillevic M; Hidalgo T; Santander-Ortega MJ; Serre C; Horcajada P
    Langmuir; 2014 May; 30(20):5911-20. PubMed ID: 24801765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heparin-engineered mesoporous iron metal-organic framework nanoparticles: toward stealth drug nanocarriers.
    Bellido E; Hidalgo T; Lozano MV; Guillevic M; Simón-Vázquez R; Santander-Ortega MJ; González-Fernández Á; Serre C; Alonso MJ; Horcajada P
    Adv Healthc Mater; 2015 Jun; 4(8):1246-57. PubMed ID: 25771896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chitosan-coated mesoporous MIL-100(Fe) nanoparticles as improved bio-compatible oral nanocarriers.
    Hidalgo T; Giménez-Marqués M; Bellido E; Avila J; Asensio MC; Salles F; Lozano MV; Guillevic M; Simón-Vázquez R; González-Fernández A; Serre C; Alonso MJ; Horcajada P
    Sci Rep; 2017 Mar; 7():43099. PubMed ID: 28256600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanoscale Iron-Based Metal-Organic Frameworks: Incorporation of Functionalized Drugs and Degradation in Biological Media.
    Christodoulou I; Lyu P; Soares CV; Patriarche G; Serre C; Maurin G; Gref R
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biocompatible Fe-Based Micropore Metal-Organic Frameworks as Sustained-Release Anticancer Drug Carriers.
    Leng X; Dong X; Wang W; Sai N; Yang C; You L; Huang H; Yin X; Ni J
    Molecules; 2018 Sep; 23(10):. PubMed ID: 30274195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design of metal organic framework-enzyme based bioelectrodes as a novel and highly sensitive biosensing platform.
    Patra S; Hidalgo Crespo T; Permyakova A; Sicard C; Serre C; Chaussé A; Steunou N; Legrand L
    J Mater Chem B; 2015 Dec; 3(46):8983-8992. PubMed ID: 32263029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multifunctional iron-based Metal-Organic framework as biodegradable nanozyme for microwave enhancing dynamic therapy.
    Ma X; Ren X; Guo X; Fu C; Wu Q; Tan L; Li H; Zhang W; Chen X; Zhong H; Meng X
    Biomaterials; 2019 Sep; 214():119223. PubMed ID: 31174065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acetic Acid-Modulated Room Temperature Synthesis of MIL-100 (Fe) Nanoparticles for Drug Delivery Applications.
    Ding M; Qiu J; Rouzière S; Rihouey C; Picton L; Gref R
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In Vitro Toxicity Study of a Porous Iron(III) Metal‒Organic Framework.
    Chen G; Leng X; Luo J; You L; Qu C; Dong X; Huang H; Yin X; Ni J
    Molecules; 2019 Mar; 24(7):. PubMed ID: 30925694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mixed-metal MIL-100(Sc,M) (M=Al, Cr, Fe) for Lewis acid catalysis and tandem C-C bond formation and alcohol oxidation.
    Mitchell L; Williamson P; Ehrlichová B; Anderson AE; Seymour VR; Ashbrook SE; Acerbi N; Daniels LM; Walton RI; Clarke ML; Wright PA
    Chemistry; 2014 Dec; 20(51):17185-97. PubMed ID: 25348903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo behavior of MIL-100 nanoparticles at early times after intravenous administration.
    Simon-Yarza T; Baati T; Neffati F; Njim L; Couvreur P; Serre C; Gref R; Najjar MF; Zakhama A; Horcajada P
    Int J Pharm; 2016 Sep; 511(2):1042-7. PubMed ID: 27515292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative study of hydrogen sulfide adsorption in the MIL-53(Al, Cr, Fe), MIL-47(V), MIL-100(Cr), and MIL-101(Cr) metal-organic frameworks at room temperature.
    Hamon L; Serre C; Devic T; Loiseau T; Millange F; Férey G; De Weireld G
    J Am Chem Soc; 2009 Jul; 131(25):8775-7. PubMed ID: 19505146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Host-guest interactions in Fe(III)-trimesate MOF nanoparticles loaded with doxorubicin.
    Anand R; Borghi F; Manoli F; Manet I; Agostoni V; Reschiglian P; Gref R; Monti S
    J Phys Chem B; 2014 Jul; 118(29):8532-9. PubMed ID: 24960194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design of Laccase-Metal Organic Framework-Based Bioelectrodes for Biocatalytic Oxygen Reduction Reaction.
    Patra S; Sene S; Mousty C; Serre C; Chaussé A; Legrand L; Steunou N
    ACS Appl Mater Interfaces; 2016 Aug; 8(31):20012-22. PubMed ID: 27447023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GraftFast Surface Engineering to Improve MOF Nanoparticles Furtiveness.
    Giménez-Marqués M; Bellido E; Berthelot T; Simón-Yarza T; Hidalgo T; Simón-Vázquez R; González-Fernández Á; Avila J; Asensio MC; Gref R; Couvreur P; Serre C; Horcajada P
    Small; 2018 Oct; 14(40):e1801900. PubMed ID: 30091524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Photoreactivity of Metal-Organic Frameworks in Aqueous Solutions: Metal Dependence of Reactive Oxygen Species Production.
    Liu K; Gao Y; Liu J; Wen Y; Zhao Y; Zhang K; Yu G
    Environ Sci Technol; 2016 Apr; 50(7):3634-40. PubMed ID: 26942867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metal Organic Framework (MOF) Particles as Potential Bacteria-Mimicking Delivery Systems for Infectious Diseases: Characterization and Cellular Internalization in Alveolar Macrophages.
    Guo A; Durymanov M; Permyakova A; Sene S; Serre C; Reineke J
    Pharm Res; 2019 Feb; 36(4):53. PubMed ID: 30790066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.